{"webUser":null}
Audioboom logo
Menu
Audioboom logo
  • Podcasts
  • Advertisers
  • Creators
  • Help & support
  • Sign up
  • Sign in
{"flashNotices":[]}
Podcasts
Advertisers
Creators
Help & support
Search podcasts
Sign up
Sign in
Podcast logo
The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest

The RIVAWAR Trial and ACS Guidelines for LV Thrombus

Episode 4,   Apr 22, 01:00 PM

Headliner
See more options
Share
Facebook X
Subscribe
Host Craig Beavers spoke with Arthur Allen, PharmD, for the latest updates from the RIVAWAR trial of rivaroxaban and a discussion of the newest Acute Coronary Syndrome Guidelines for left ventricular thrombus.

For more information:
  • Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association
  • Anticoagulation Forum Rapid Resources LV Thrombus
  • 2025 ACC/AHA Guidelines
  • ACC 2025: Rivaroxaban Comparable to Warfarin in Left Ventricular Blood Clots
Share
Facebook X
Subscribe
Next
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
Top episodes
Everything You Need to Know from the American College of Cardiology 2025 Scientific Session
by The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
Updates to Acute Coronary Syndrome Guidelines
by The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
by The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
  •   Report this episode
  •   Download audio
  •   QRCode
For podcasters For advertisers For listeners
Help & feedback About us Blog Investor relations
Cookie policy Privacy policy Terms & conditions
©2025 Audioboom

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

Page load failed

Please check your internet connection and refresh the page. You might also try disabling any ad blockers.

You can visit our support center if you're having problems.